Skip to main content
Venus Medtech (Hangzhou) Inc. logo

Venus Medtech (Hangzhou) Inc. — Investor Relations & Filings

Ticker · 2500 ISIN · CNE100003PJ8 HKEX Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2024-11-19 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 2500

About Venus Medtech (Hangzhou) Inc.

http://www.venusmedtech.com

Venus Medtech (Hangzhou) Inc. is an innovation-driven medical device company specializing in the research, development, manufacturing, and commercialization of transcatheter solutions for structural heart diseases. The company focuses on bioprosthetic heart valves, establishing a comprehensive pipeline that addresses aortic, pulmonary, mitral, and tricuspid valve diseases. Its product portfolio includes transcatheter aortic valve replacement (TAVR) solutions, and it is committed to addressing unmet demand in TPVR and TMVR. The company also develops solutions for hypertension, such as renal artery denervation ablation, and related surgical accessory products. Its products are commercialized globally, reaching over 60 countries and regions across Asia, Europe, and the Americas.

Recent filings

Filing Released Lang Actions
PROXY FORM FOR USE AT THE 2024 SECOND EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for the 2024 Second Extraordinary General Meeting of Venus Medtech (Hangzhou) Inc. It includes instructions for shareholders to appoint proxies to vote on resolutions at the meeting, including election of a director, amendments to the Articles of Association, and granting a general mandate to issue shares. The document is not a report or announcement of financial results, nor is it a regulatory filing or certification. It is a material sent to shareholders to provide information and request votes for a meeting, which fits the definition of a Proxy Solicitation & Information Statement (PSI). The document length is 7507 characters, which is consistent with a detailed proxy form. Therefore, the correct classification is PSI.
2024-11-19 English
NOTICE OF 2024 SECOND CLASS MEETING OF HOLDERS OF UNLISTED FOREIGN SHARES
AGM Information Classification · 95% confidence The document is a notice for a 2024 Second Class Meeting of Holders of Unlisted Foreign Shares of Venus Medtech (Hangzhou) Inc. It includes details about the meeting date, location, agenda (special resolutions), proxy voting instructions, and shareholder rights. It is a formal announcement inviting shareholders to attend and vote on specific resolutions. There is no financial data, no report content, no earnings or management discussion, and no voting results. The document is a meeting notice, which is a type of shareholder meeting announcement. According to the filing definitions, announcements of shareholder meetings and related materials fall under AGM Information (AGM-R) if they are materials shared during the Annual General Meeting or similar shareholder meetings. Since this is a notice of a class meeting of shareholders, it fits best under AGM Information (AGM-R). The document length is 5717 characters, which is consistent with a detailed meeting notice rather than a brief announcement or a full report. Therefore, the classification is AGM-R with high confidence.
2024-11-19 English
NOTICE OF 2024 SECOND CLASS MEETING OF HOLDERS OF H SHARES
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for a 2024 Second Class Meeting of Holders of H Shares of Venus Medtech (Hangzhou) Inc. It includes details about the meeting date, location, agenda (special resolutions), proxy voting instructions, and shareholder registration. It is a formal announcement inviting shareholders to attend and vote on specific resolutions. There is no financial data, no report attached or referenced as being published, and no detailed presentation or management discussion. The document is clearly a meeting notice rather than a report or results announcement. This fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The length (5674 characters) and content confirm it is not a brief announcement or a full report but a detailed notice for a shareholder meeting with voting information.
2024-11-19 English
NOTICE OF 2024 SECOND EXTRAORDINARY GENERAL MEETING
AGM Information Classification · 95% confidence The document is a notice for the 2024 Second Extraordinary General Meeting (EGM) of Venus Medtech (Hangzhou) Inc. It includes details about the meeting date, location, agenda items such as election of a director, amendments to articles of association, and a general mandate to issue shares. The document is a formal announcement inviting shareholders to attend and vote at the meeting, with procedural notes on registration, proxy appointments, and voting methods. There are no financial statements, management discussion, or detailed financial data presented. The document is not a report but a meeting notice. Therefore, it fits the category of a meeting notice, which aligns with AGM Information (AGM-R) as it is a notice for a general meeting (extraordinary general meeting).
2024-11-19 English
(1) PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION (3) OTHER PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION (4) GENERAL MANDATE T
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from the board of Venus Medtech (Hangzhou) Inc. regarding the appointment of an independent non-executive director, proposed amendments to the articles of association, a general mandate to issue shares, and notices of extraordinary general meeting and class meetings. It includes proxy forms and detailed notices for shareholder meetings. The content is focused on governance matters, shareholder meetings, and voting, rather than financial results or audit information. The document is lengthy (15,000 characters) and contains detailed meeting notices and resolutions to be voted on. This fits the definition of Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings. It is not a simple announcement or notice of a report, nor is it a full annual or interim report, audit report, or earnings release. Therefore, the appropriate classification is PSI with high confidence.
2024-11-19 English
(1) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION IN RELATION TO LISTING RULE 2.07A (3) OTHER PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIAT
Board/Management Information Classification · 100% confidence The document is an announcement from Venus Medtech (Hangzhou) Inc. regarding the appointment of an independent non-executive director, proposed amendments to the Articles of Association, and closure of the register of members for an upcoming extraordinary general meeting (EGM). It includes detailed biographical information about the new director, references to compliance with Listing Rules, and procedural details about the EGM. The document does not contain financial statements or financial performance data, nor is it a transcript or presentation. It is a formal announcement about board/management changes and corporate governance matters. Therefore, it fits best under the category of Board/Management Information (MANG).
2024-11-12 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.